cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.25070009.v1
title: Supplementary materials: Justifying the source of external comparators in single-arm oncology health technology submissions: a review of NICE and PBAC assessments

description: <b>These are peer-reviewed supplementary tables for the article '</b><b>Justifying the source of external comparators in single-arm oncology health technology submissions: a review of NICE and PBAC assessments</b><b>' published in the</b><b> </b><b><i>Journal of Comparative Effectiveness Research</i></b><b>.</b><br><b>Supplemental Table 1: </b>Summary of included submissions<b>Supplemental Table 2:</b> Main external control critiques across NICE and PBAC submissions for the same technologies<b>Background: </b>The drive to expedite patient access for diseases with high unmet treatment needs has come with an increasing use of single-arm trials (SATs), especially in oncology. However, the lack of control arms in such trials creates challenges to assess and demonstrate comparative efficacy. External control (EC) arms can be used to bridge this gap, with various types of sources available to obtain relevant data. <b>Objective:</b> To examine the source of ECs in single-arm oncology health technology assessment (HTA) submissions to the National Institute for Health and Care Excellence (NICE) and the Pharmaceutical Benefits Advisory Committee (PBAC) and how this selection was justified by manufacturers and assessed by the respective HTA body. <b>Methods:</b> Single-arm oncology HTA submission reports published by NICE (England) and PBAC (Australia) from January 2011 to August 2021 were reviewed, with data qualitatively synthesized to identify themes. <b>Results:</b> Forty-eight oncology submissions using EC arms between 2011 and 2021 were identified, with most submissions encompassing blood and bone marrow cancers (52%). In HTA submissions to NICE and PBAC, the EC arm was typically constructed from a combination of data sources, with the company’s justification in data source selection infrequently provided (PBAC [2 out of 19]; NICE [6 out of 29]), although this lack of justification was not heavily criticized by either HTA body. <b>Conclusion:</b> Although HTA bodies such as NICE and PBAC encourage that EC source justification should be provided in submissions, this review found that this is not typically implemented in practice. Guidance is needed to establish best practices as to how EC selection should be documented in HTA submissions.
DOI: 10.6084/m9.figshare.25070009
title: Supplementary materials: Justifying the source of external comparators in single-arm oncology health technology submissions: a review of NICE and PBAC assessments

description: <b>These are peer-reviewed supplementary tables for the article '</b><b>Justifying the source of external comparators in single-arm oncology health technology submissions: a review of NICE and PBAC assessments</b><b>' published in the</b><b> </b><b><i>Journal of Comparative Effectiveness Research</i></b><b>.</b><br><b>Supplemental Table 1: </b>Summary of included submissions<b>Supplemental Table 2:</b> Main external control critiques across NICE and PBAC submissions for the same technologies<b>Background: </b>The drive to expedite patient access for diseases with high unmet treatment needs has come with an increasing use of single-arm trials (SATs), especially in oncology. However, the lack of control arms in such trials creates challenges to assess and demonstrate comparative efficacy. External control (EC) arms can be used to bridge this gap, with various types of sources available to obtain relevant data. <b>Objective:</b> To examine the source of ECs in single-arm oncology health technology assessment (HTA) submissions to the National Institute for Health and Care Excellence (NICE) and the Pharmaceutical Benefits Advisory Committee (PBAC) and how this selection was justified by manufacturers and assessed by the respective HTA body. <b>Methods:</b> Single-arm oncology HTA submission reports published by NICE (England) and PBAC (Australia) from January 2011 to August 2021 were reviewed, with data qualitatively synthesized to identify themes. <b>Results:</b> Forty-eight oncology submissions using EC arms between 2011 and 2021 were identified, with most submissions encompassing blood and bone marrow cancers (52%). In HTA submissions to NICE and PBAC, the EC arm was typically constructed from a combination of data sources, with the company’s justification in data source selection infrequently provided (PBAC [2 out of 19]; NICE [6 out of 29]), although this lack of justification was not heavily criticized by either HTA body. <b>Conclusion:</b> Although HTA bodies such as NICE and PBAC encourage that EC source justification should be provided in submissions, this review found that this is not typically implemented in practice. Guidance is needed to establish best practices as to how EC selection should be documented in HTA submissions.
DOI: 10.6084/m9.figshare.25069163
title: Supplementary data: Real-world use of inotuzumab ozogamicinis associated with lower health care costs than blinatumomab in patients with acute lymphoblastic leukemia in the first relapsed/refractory setting

description: <b>These are peer-reviewed supplementary tables for the article '</b><b>Real-world use of inotuzumab ozogamicinis associated with lower health care costs than blinatumomab in patients with acute lymphoblastic leukemia in the first relapsed/refractory setting</b><b>' published in the</b><b> </b><b><i>Journal of Comparative Effectiveness Research</i></b><b>.</b><br><b>Supplementary Table 1: </b>Unweighted baseline demographic characteristics among patients with acute lymphoblastic leukemia in first relapsed/refractory setting<b>Supplementary Table 2: </b>Inverse probability treatment weighted baseline comorbidities for patients with acute lymphoblastic leukemia receiving InO and Blina in the first relapsed/refractory setting<b>Aim:</b> To compare all-cause and acute lymphoblastic leukemia (ALL)-related healthcare resource utilization (HCRU) and costs among patients receiving inotuzumab ozogamicin (InO) and blinatumomab (Blina) for ALL in the first relapsed/refractory (R/R) setting. <b>Patients & methods:</b> We studied retrospective claims for adult commercial and Medicare Advantage enrollees with ALL receiving InO (n = 29) or Blina (n = 23) from 1 January 2015 to 16 February 2021. Mean per-patient-per-month (PPPM) HCRU and total costs were described and multivariable-adjusted PPPM total all-cause and ALL-related predicted costs were calculated. <b>Results:</b> Mean monthly ALL-related hospitalizations were the same for patients receiving InO and Blina (PPPM = 0.8 stays); however, the length of ALL-related hospital stay was almost twice as long among patients receiving Blina versus InO (ALL-related: InO = 7.6 days; Blina = 14.1 days; p = 0.346). In multivariable models, total ALL-related costs were 43% lower for InO compared with Blina (PPPM costs: InO = $93,767; Blina = $163,470; p = 0.021). <b>Conclusion:</b> In the first R/R setting, patients who used InO had significantly lower all-cause and ALL-related costs compared with patients who used Blina, in part driven by hospitalization patterns.
DOI: 10.6084/m9.figshare.25069163.v1
title: Supplementary data: Real-world use of inotuzumab ozogamicinis associated with lower health care costs than blinatumomab in patients with acute lymphoblastic leukemia in the first relapsed/refractory setting

description: <b>These are peer-reviewed supplementary tables for the article '</b><b>Real-world use of inotuzumab ozogamicinis associated with lower health care costs than blinatumomab in patients with acute lymphoblastic leukemia in the first relapsed/refractory setting</b><b>' published in the</b><b> </b><b><i>Journal of Comparative Effectiveness Research</i></b><b>.</b><br><b>Supplementary Table 1: </b>Unweighted baseline demographic characteristics among patients with acute lymphoblastic leukemia in first relapsed/refractory setting<b>Supplementary Table 2: </b>Inverse probability treatment weighted baseline comorbidities for patients with acute lymphoblastic leukemia receiving InO and Blina in the first relapsed/refractory setting<b>Aim:</b> To compare all-cause and acute lymphoblastic leukemia (ALL)-related healthcare resource utilization (HCRU) and costs among patients receiving inotuzumab ozogamicin (InO) and blinatumomab (Blina) for ALL in the first relapsed/refractory (R/R) setting. <b>Patients & methods:</b> We studied retrospective claims for adult commercial and Medicare Advantage enrollees with ALL receiving InO (n = 29) or Blina (n = 23) from 1 January 2015 to 16 February 2021. Mean per-patient-per-month (PPPM) HCRU and total costs were described and multivariable-adjusted PPPM total all-cause and ALL-related predicted costs were calculated. <b>Results:</b> Mean monthly ALL-related hospitalizations were the same for patients receiving InO and Blina (PPPM = 0.8 stays); however, the length of ALL-related hospital stay was almost twice as long among patients receiving Blina versus InO (ALL-related: InO = 7.6 days; Blina = 14.1 days; p = 0.346). In multivariable models, total ALL-related costs were 43% lower for InO compared with Blina (PPPM costs: InO = $93,767; Blina = $163,470; p = 0.021). <b>Conclusion:</b> In the first R/R setting, patients who used InO had significantly lower all-cause and ALL-related costs compared with patients who used Blina, in part driven by hospitalization patterns.
DOI: 10.20375/0000-0011-672c-9
title: Documentation-Data-Collection-DIF_CPS_July2023_Odesa.pdf
DOI: 10.20375/0000-0011-672d-8
title: ODS0723-questionnaire.pdf
DOI: 10.20375/0000-0011-672e-7
title: ODS0723.sav
DOI: 10.20375/0000-0011-672f-6
title: ODS0723.xlsx
DOI: 10.5525/gla.researchdata.1568
title: Prevalence and risk factors for Q fever, spotted fever group rickettsioses, and typhus group rickettsioses in a pastoralist community of northern Tanzania, 2016-2017

description: Excel file including all data fields included in the analyses presented in the paper, except for any fields where inclusion might compromise participant anonymity.
DOI: 10.20375/0000-0011-6730-3
title: Selected Results.pdf
DOI: 10.48320/799f8957-f707-4747-97ce-bb4fbbea1c96
title: Democracy, Trust in Government Institutions, War, Media Consumption: Regional Poll in Odesa Region (Ilko Kucheriv Democratic Initiatives Foundation)
DOI: 10.25318/1510003601-eng
title: Population by first official language spoken, immigrant status, period of immigration and geography, 1971 to 2021

description: First official language spoken by immigrant status and period of immigration for the population of Canada and Canada outside Quebec, and of all provinces and territories, for Census years 1971 to 2021.
DOI: 10.24403/jp.1318912
title: Arbeitskreise Heimische Orchideen (Hrsg.): Die Orchideen Deutschlands. - Uhlstädt-Kirchhasel, 2005 / [rezensiert von] H. Korsch
DOI: 10.24403/jp.1318917
title: Meyer, N., Meierott, L., Schuwerk, H. & Angerer, O.: Beiträge zur Gattung Sorbus. Ber. Bayer. Bot. Ges. Sonderband. - Selbstverlag der Gesellschaft, München 2005. / [rezensiert von] Volker Wissemann
DOI: 10.24403/jp.1320044
title: Volker Harlan (Hrsg.): Wert und Grenzen des Typus in der botanischen Morphologie. Wissenschaftliche Schriftenreihe des Instituts für Evolutionsbiologie und Morphologie in der Universität Witten/Herdecke. - Martina-Galunder-Verlag, 2005 / [rezensiert von] Volker Harlan
DOI: 10.25318/1510003601-fra
title: Population selon la première langue officielle parlée, le statut d'immigrant, la période d'immigration et la géographie, 1971 à 2021

description: Première langue officielle parlée selon le statut d'immigrant et la période d'immigration pour la population du Canada et du Canada hors Québec, et de toutes les provinces et tous les territoires, pour les années de recensement de 1971 à 2021.
DOI: 10.15131/shef.data.24125721
title: Development of InGaAs/AlGaAsSb Geiger mode Avalanche Photodiodes: Dataset and Figures

description: Datasets of the figures found in the manuscript "Development of InGaAs/AlGaAsSb Geiger mode Avalanche Photodiodes"Files in this repository correspond to the results in "Development of InGaAs/AlGaAsSb Geiger mode Avalanche Photodiodes" submitted to IEEE Transactions on Electron Devices.The figure files contain the graphical figures (.png) found within the manuscript and the data (.csv) require to replicate the figures. Manuscript Abstract:Near-infrared linear mode Al<sub>0.85</sub>Ga<sub>0.15</sub>As<sub>0.56</sub>Sb<sub>0.44</sub> avalanche photodiodes (APDs) exhibit excellent temperature stability, potentially simplifying Geiger mode operation. We have carried out the first experimental evaluation of In<sub>0.53</sub>Ga<sub>0.47</sub>As/Al<sub>0.85</sub>Ga<sub>0.15</sub>As<sub>0.56</sub>Sb<sub>0.44</sub> APDs in Geiger mode. Characterization on multiple devices included temperature-dependent dark current, avalanche multiplication, dark count rate (DCR), afterpulsing, and single photon detection efficiency (SPDE). The temperature coefficient of breakdown voltage extracted from avalanche multiplication data was 13.5 mV.K<sup>−1</sup>, much lower than InGaAs/InP Geiger mode APDs, reducing changes in operation voltage and offering possible protection from high optical power thermal attack in communication systems. At 200 K, SPDE were 5%–16% with DCR of 1–20 Mc·s<sup>−1</sup>, comparable to InAlAs and early InP-based Single Photon APDs. The afterpulsing at 200 K was negligible for hold-off time &gt;50 µs (reducing to 5 µs at 250 K). These are similar to the performance of InGaAs/InAlAs and some InGaAs/InP Geiger mode APDs.
DOI: 10.15131/shef.data.24125721.v1
title: Development of InGaAs/AlGaAsSb Geiger mode Avalanche Photodiodes: Dataset and Figures

description: Datasets of the figures found in the manuscript "Development of InGaAs/AlGaAsSb Geiger mode Avalanche Photodiodes"Files in this repository correspond to the results in "Development of InGaAs/AlGaAsSb Geiger mode Avalanche Photodiodes" submitted to IEEE Transactions on Electron Devices.The figure files contain the graphical figures (.png) found within the manuscript and the data (.csv) require to replicate the figures. Manuscript Abstract:Near-infrared linear mode Al<sub>0.85</sub>Ga<sub>0.15</sub>As<sub>0.56</sub>Sb<sub>0.44</sub> avalanche photodiodes (APDs) exhibit excellent temperature stability, potentially simplifying Geiger mode operation. We have carried out the first experimental evaluation of In<sub>0.53</sub>Ga<sub>0.47</sub>As/Al<sub>0.85</sub>Ga<sub>0.15</sub>As<sub>0.56</sub>Sb<sub>0.44</sub> APDs in Geiger mode. Characterization on multiple devices included temperature-dependent dark current, avalanche multiplication, dark count rate (DCR), afterpulsing, and single photon detection efficiency (SPDE). The temperature coefficient of breakdown voltage extracted from avalanche multiplication data was 13.5 mV.K<sup>−1</sup>, much lower than InGaAs/InP Geiger mode APDs, reducing changes in operation voltage and offering possible protection from high optical power thermal attack in communication systems. At 200 K, SPDE were 5%–16% with DCR of 1–20 Mc·s<sup>−1</sup>, comparable to InAlAs and early InP-based Single Photon APDs. The afterpulsing at 200 K was negligible for hold-off time &gt;50 µs (reducing to 5 µs at 250 K). These are similar to the performance of InGaAs/InAlAs and some InGaAs/InP Geiger mode APDs.
DOI: 10.5519/qd.oqraymdy
title: Query on the Natural History Museum Data Portal (data.nhm.ac.uk) (1 records)
DOI: 10.24403/jp.1328628
title: Dicranum viride (Sull. & Lesq.) Lindb. in Thüringen - Lebensraum, Vergesellschaftung, Verbreitung, Bestandsentwicklung, Schutz / Hjalmar Thiel ; Markus Preußing
DOI: 10.5281/zenodo.10461892
title: Decoding the thermal history of merging cluster Cygnus A (Part 1)

description: Data reproduction package for the paper "Decoding the thermal history of merging cluster Cygnus A" by Anwesh Majumder, M.W. Wise, A. Simionescu, M.N. de Vries (published in MNRAS). This is part 1. Part 2 can be found here: 10.5281/zenodo.10462251

Arxiv: https://arxiv.org/abs/2401.02912

DOI: 10.1093/mnras/stae063

Raw data: The Chandra and XMM data can be downloaded from https://cda.harvard.edu/chaser/ and http://nxsa.esac.esa.int/nxsa-web/#search . See the 'Data' section of the paper to know what to download. Any additional data source has been mentioned in the paper as footnotes.

Software required:

CIAO (https://cxc.cfa.harvard.edu/ciao/)

XMM-SAS (https://www.cosmos.esa.int/web/xmm-newton/download-and-install-sas)

Jupyter Notebook and Python-3.7 or higher (https://jupyter.org)

MARX (https://space.mit.edu/cxc/marx/)

SIMPUT (https://www.sternwarte.uni-erlangen.de/sixte/installation/)

PyxSIM (https://hea-www.cfa.harvard.edu/~jzuhone/pyxsim/)

This upload contains XMM and Chandra data analysis files and notebooks. There are README files inside directories. Untar these files to get a description.
DOI: 10.5281/zenodo.10461893
title: Decoding the thermal history of merging cluster Cygnus A (Part 1)

description: Data reproduction package for the paper "Decoding the thermal history of merging cluster Cygnus A" by Anwesh Majumder, M.W. Wise, A. Simionescu, M.N. de Vries (published in MNRAS). This is part 1. Part 2 can be found here: 10.5281/zenodo.10462251

Arxiv: https://arxiv.org/abs/2401.02912

DOI: 10.1093/mnras/stae063

Raw data: The Chandra and XMM data can be downloaded from https://cda.harvard.edu/chaser/ and http://nxsa.esac.esa.int/nxsa-web/#search . See the 'Data' section of the paper to know what to download. Any additional data source has been mentioned in the paper as footnotes.

Software required:

CIAO (https://cxc.cfa.harvard.edu/ciao/)

XMM-SAS (https://www.cosmos.esa.int/web/xmm-newton/download-and-install-sas)

Jupyter Notebook and Python-3.7 or higher (https://jupyter.org)

MARX (https://space.mit.edu/cxc/marx/)

SIMPUT (https://www.sternwarte.uni-erlangen.de/sixte/installation/)

PyxSIM (https://hea-www.cfa.harvard.edu/~jzuhone/pyxsim/)

This upload contains XMM and Chandra data analysis files and notebooks. There are README files inside directories. Untar these files to get a description.
DOI: 10.5519/qd.jehfzuiq
title: Query on the Natural History Museum Data Portal (data.nhm.ac.uk) (5770908 records)
DOI: 10.18167/dvn1/wcva7z
title: Dataset on weed sampling, biomass and rice yield to determine critical period of weed interference in rainfed low-input cropping systems in the middle-west region of Madagascar

description: Full dataset (raw data calculated at plot level) on weed biomass, Weed cover, weed surveys and rice yield, tiller number and height based on a experiment to determine the critical period of weed interference in the middle-west region of Madagascar on two cropping seasons (2016/17 and 2017/18).
DOI: 10.5281/zenodo.10462250
title: Decoding the thermal history of merging cluster Cygnus A (Part 2)

description: Data reproduction package for the paper "Decoding the thermal history of merging cluster Cygnus A" by Anwesh Majumder, M.W. Wise, A. Simionescu, M.N. de Vries (published in MNRAS). This is Part 2. Part 1 can be found here: 10.5281/zenodo.10461893

Arxiv: https://arxiv.org/abs/2401.02912

DOI: 10.1093/mnras/stae063

Raw data: The Chandra and XMM data can be downloaded from https://cda.harvard.edu/chaser/ and http://nxsa.esac.esa.int/nxsa-web/#search . See the 'Data' section of the paper to know what to download. Any additional data source has been mentioned in the paper as footnotes.

Software required:

CIAO (https://cxc.cfa.harvard.edu/ciao/)

XMM-SAS (https://www.cosmos.esa.int/web/xmm-newton/download-and-install-sas)

Jupyter Notebook and Python-3.7 or higher (https://jupyter.org)

MARX (https://space.mit.edu/cxc/marx/)

SIMPUT (https://www.sternwarte.uni-erlangen.de/sixte/installation/)

PyxSIM (https://hea-www.cfa.harvard.edu/~jzuhone/pyxsim/)

This upload contains simulation files and related notebooks. There are README files inside directories. Untar these files to get a description.
DOI: 10.5281/zenodo.10462251
title: Decoding the thermal history of merging cluster Cygnus A (Part 2)

description: Data reproduction package for the paper "Decoding the thermal history of merging cluster Cygnus A" by Anwesh Majumder, M.W. Wise, A. Simionescu, M.N. de Vries (published in MNRAS). This is Part 2. Part 1 can be found here: 10.5281/zenodo.10461893

Arxiv: https://arxiv.org/abs/2401.02912

DOI: 10.1093/mnras/stae063

Raw data: The Chandra and XMM data can be downloaded from https://cda.harvard.edu/chaser/ and http://nxsa.esac.esa.int/nxsa-web/#search . See the 'Data' section of the paper to know what to download. Any additional data source has been mentioned in the paper as footnotes.

Software required:

CIAO (https://cxc.cfa.harvard.edu/ciao/)

XMM-SAS (https://www.cosmos.esa.int/web/xmm-newton/download-and-install-sas)

Jupyter Notebook and Python-3.7 or higher (https://jupyter.org)

MARX (https://space.mit.edu/cxc/marx/)

SIMPUT (https://www.sternwarte.uni-erlangen.de/sixte/installation/)

PyxSIM (https://hea-www.cfa.harvard.edu/~jzuhone/pyxsim/)

This upload contains simulation files and related notebooks. There are README files inside directories. Untar these files to get a description.
DOI: 10.24403/jp.1329156
title: Hermann von Nördlingers Holzquerschnitte : eine Bestandsaufnahme der Bände I-IV der Universitätsbibliothek Jena / Ben Bubner
DOI: 10.25318/1510003701-eng
title: Population by knowledge of official languages, immigrant status, period of immigration and geography, 1951 to 2021

description: Knowledge of official languages by immigrant status and period of immigration for the population of Canada and Canada outside Quebec, and of all provinces and territories, for Census years 1951 to 2021.
DOI: 10.4119/unibi/2986705
title: Arrhythmogenic cardiomyopathy-related cadherin variants affect desmosomal binding kinetics
DOI: 10.5517/ccdc.csd.cc2bt71g
title: CCDC 2169195: Experimental Crystal Structure Determination

description: Related Article: Yangbin Xie, Songshan Dai, Yue Wang, Xi Wang, Ying Sun, Zhenghua Ju, Ran Fang, Baoxin Zhang, Jincai Wu, Xiaoxiang Zhang, Xiaobo Pan|2023|CrystEngComm|25|2204|doi:10.1039/D2CE01590K
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2bt72h
title: CCDC 2169196: Experimental Crystal Structure Determination

description: Related Article: Yangbin Xie, Songshan Dai, Yue Wang, Xi Wang, Ying Sun, Zhenghua Ju, Ran Fang, Baoxin Zhang, Jincai Wu, Xiaoxiang Zhang, Xiaobo Pan|2023|CrystEngComm|25|2204|doi:10.1039/D2CE01590K
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2h5yrd
title: CCDC 2299634: Experimental Crystal Structure Determination

description: Related Article: Julian D. Farmer, Paul J. Low, Dmitry S. Yufit, Judith A. K. Howard|2023|CSD Communication|||
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.